Dermatology
Conference Coverage
Clinical clarity grows about toenail disorder, experts report
Retronychia is usually a clinical diagnosis based on the presence of the increased bulk of the toenail when overlapping nails cannot be seen.
Conference Coverage
New trial data show hair growth in more alopecia areata patients
“Every time we add 16 weeks of data across hundreds of patients, we are making a huge step forward toward the goal of FDA approval for a...
Conference Coverage
Aluminum named allergen of the year
Reactions normally present as itchy nodules that can last for months and even years.
Conference Coverage
COVID-19 infection linked to risk of cutaneous autoimmune and vascular diseases
“Our theory is that the severe inflammatory nature of COVID-19 leads to a lot of internal organ damage and exposure of autoantigens in that...
From the Journals
Trial gives new guidance for choosing initial PsA treatment
Adding the tumor necrosis factor inhibitor adalimumab to methotrexate because of a lack of efficacy or tolerability produced better results than...
Latest News
Adverse skin effects of cancer immunotherapy reviewed
“The desirable, immune-mediated oncologic response is often achieved at the cost of immune-related adverse events (irAEs) that may potentially...
Latest News
COVID-19–alopecia areata link? Review doesn’t find much evidence
Few reports have connected the two conditions.
Opinion
A 31-year-old female presented with a burning rash on upper arms, groin, and axillae
A 31-year-old female with a 10-year history of mild scalp psoriasis presented with a worsening itchy and burning rash on upper arms, groin, and...
Latest News
Study links air pollution to psoriasis flares
The findings underscore the need for clinicians to “consider environmental/external triggers in patients with chronic inflammatory diseases...
From the Journals
Drug survival study looks at what lasts longest in RA, axSpA, PsA, and psoriasis
Survival rates were highest for rituximab in rheumatoid arthritis and golimumab in axial spondyloarthritis in a study of two Danish registries.
Latest News
Complex link between gut microbiome and immunotherapy response in advanced melanoma
Previous studies have identified the gut microbiome as “a potential biomarker of response as well as a therapeutic target” in melanoma and other...